Hyperglicemia in childhood acute lymphoblastic leukemia during induction chemotherapy

• Main Authors: Nengcy Erlina Tasik Rerung, -, Andi Cahyadi, -, Nur Rochmah, -, Maria Christina Shanty Larasati, -, Mia Ratwita Andarsini, -, Muhammad Faizi, -
• Format: Article PeerReviewed
• Language: English; English; English; English
• Published: Institute of Medico-legal Publications 2020
• Subjects: R Medicine (General); RJ Pediatrics
• Online Access: https://repository.unair.ac.id/127590/1/32%20-%20Artikel.pdf; https://repository.unair.ac.id/127590/2/32%20-%20Kualitas%20Karil.pdf; https://repository.unair.ac.id/127590/3/32%20-%20Turnitin.pdf; https://repository.unair.ac.id/127590/7/Karil%20-%20Hyperglicemia%20in%20childhood%20acute%20lymphoblastic%20leukemia%20during%20induction%20chemotherapy.pdf; https://repository.unair.ac.id/127590/; https://medicopublication.com/index.php/ijfmt/article/view/13605
• Institution: Universitas Airlangga

Background: Hyperglycemia is a recognized side effect of the corticosteroids and asparaginase given during induction chemotherapy for pediatric acute lymphoblastic leukemia (ALL). The ALL is the malignant tumor with the highest incidence in the childhood. The aim of this study is to investigate the...